IPath Series Valuation
| VXZ Etf | USD 59.06 0.00 0.00% |
At this time, the entity appears to be overvalued. iPath Series B retains a regular Real Value of $54.41 per share. The prevalent price of the entity is $59.06. Our model calculates the value of iPath Series B from examining the entity fundamentals such as Beta of 8.18, number of employees of 127, and Net Asset of 47.78 M as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that IPath Series' price fluctuation is very steady at this time. Calculation of the real value of iPath Series B is based on 3 months time horizon. Increasing IPath Series' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since IPath Series is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IPath Etf. However, IPath Series' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 59.06 | Real 54.41 | Hype 59.06 | Naive 61.17 |
The intrinsic value of IPath Series' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence IPath Series' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of iPath Series B helps investors to forecast how IPath etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IPath Series more accurately as focusing exclusively on IPath Series' fundamentals will not take into account other important factors: About IPath Series Valuation
Our relative valuation model uses a comparative analysis of IPath Series. We calculate exposure to IPath Series's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IPath Series's related companies. When determining whether iPath Series B offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IPath Series' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ipath Series B Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ipath Series B Etf:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in iPath Series B. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of iPath Series B is measured differently than its book value, which is the value of IPath that is recorded on the company's balance sheet. Investors also form their own opinion of IPath Series' value that differs from its market value or its book value, called intrinsic value, which is IPath Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IPath Series' market value can be influenced by many factors that don't directly affect IPath Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IPath Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.